学术周报 · IF≥10 或专科旗舰刊
耳鼻喉科领域文献阅读汇编
2026年第47周 (2026-11-20) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
★本周 Top 10 高影响力文献
Ŧ期刊分布统计
| 期刊 | 篇数 | IF |
|---|---|---|
| The Laryngoscope | 9 | IF 2.0 |
| JAMA otolaryngology-- head & neck surgery | 2 | IF 7.0 |
| Kidney international | 1 | IF 21.8 |
| Journal of hazardous materials | 1 | IF 10.6 |
| American journal of clinical dermatology | 1 | IF 11.4 |
1耳科与听力学 (4篇)
临床研究 (2篇)
We present a 52-year-old male with antiphospholipid syndrome who developed acute left-sided sudden sensorineural hearing loss (SSNHL), tinnitus, and vertigo during an anticoagulation gap. Bedside head impulse testing (HIT) identified vestibulo-ocular reflex deficits localizing dysfunction to two distinct labyrinthine vascular territories, consistent with bilateral microvascular occlusion. In conjunction with targeted neurological examination, HIT provides a rapid means of localizing peripheral audiovestibular injury and distinguishing it from ischemic central etiologies.
中文摘要:我们报告了一例52岁男性抗磷脂综合征患者,其在抗凝治疗间隙出现急性左侧突发性感音神经性听力损失、耳鸣和眩晕。床旁头脉冲试验显示前庭眼反射缺陷,提示功能障碍定位于两个不同的迷路血管区域,符合双侧微血管闭塞的特征。结合针对性神经系统检查,头脉冲试验提供了一种快速定位周围听觉前庭损伤并区分缺血性中枢病因的快速方法。
Factors Associated With Magnet Retention Issues in Cochlear Implants: A Single Institution Analysis.
To identify clinical and anatomic factors associated with magnet retention issues and high magnet strength requirements in patients undergoing cochlear implantation. Retrospective chart review of adult patients (n = 168) who underwent cochlear implantation at a tertiary academic medical center between 2018 and 2023. Data was collected on the following variables: age, BMI at time of surgery, preoperative scalp thickness, magnet type (axial vs. diametric), processor type (behind-the-ear [BTE] vs. off-the-ear [OTE]), and postoperative retention issues (inability to use intended processor, need for compression/hair shaving, delayed activation, or revision surgery). Statistical analysis was performed via chi-square, Fisher's exact, and logistic regression. Out of 168 ears, 13.5% had magnet retention issues. Forty-eight percent of BTE users needed a high magnet strength (> 3) or had retention issues. OTE processors had higher retention issues rates than BTE, especially with diametric magnets. Magnet retention was significantly higher for patients younger than 45 (OR 6.88) and with BMI ≥ 30 (OR 9.85). Those with diametric magnets were at much higher risk than those with axial magnets (17.6% vs. 2.0%) and OTE processors were strongly associated with retention failure (23.1% vs. 4.3%). Age < 45 and BMI ≥ 30 are useful predictors of high magnet strength or retention issues. Clinicians may use these parameters during preoperative counseling and consider using preoperative CT imaging to assess scalp thickness for these high-risk patients. Physician counseling for these patients should include the likelihood of increased retention issues, especially with OTE processors. III.
中文摘要:本研究旨在识别与人工耳蜗植入患者磁铁固定问题及高磁铁强度需求相关的临床和解剖因素。对2018年至2023年间在三级学术医学中心接受人工耳蜗植入的成年患者(n=168)进行了回顾性病历审查。收集的数据变量包括:年龄、手术时的体重指数(BMI)、术前头皮厚度、磁铁类型(轴向与径向)、处理器类型(耳后式BTE与离体式OTE)以及术后固定问题(无法使用预期处理器、需要加压或剃发、延迟激活或翻修手术)。通过卡方检验、Fisher精确检验和逻辑回归进行统计分析。在168例耳部中,13.5%存在磁铁固定问题。48%的BTE用户需要高磁铁强度(>3)或存在固定问题。OTE处理器的固定问题发生率高于BTE,尤其是使用径向磁铁时。年龄小于45岁(OR 6.88)和BMI≥30(OR 9.85)的患者磁铁固定风险显著更高。与轴向磁铁相比,径向磁铁患者的风险高得多(17.6% vs. 2.0%),且OTE处理器与固定失败强烈相关(23.1% vs. 4.3%)。年龄小于45岁和BMI≥30是高磁铁强度或固定问题的有用预测指标。临床医生可在术前咨询中使用这些参数,并考虑对高危患者使用术前CT成像评估头皮厚度。对这些患者的医师咨询应包括增加固定问题的可能性,尤其是使用OTE处理器时。
基础研究 (2篇)
Alport syndrome (AS) is the second most common genetic kidney disease. It is an inherited disorder of type IV collagen, the main structural component of the glomerular basement membrane (GBM), caused by pathogenic variants in the genes COL4A3, COL4A4, and COL4A5 encoding the alpha 3, alpha 4 or alpha 5 collagen IV chains (α3/α4/α5[IV]). This leads to GBM defects, clinically presenting with microscopic hematuria and/or proteinuria and is variably associated with sensorineural hearing loss and ophthalmological defects. During the first half of the century, clinicians refined the phenotype, while pathologists and biochemists elucidated the structural anomalies of basement membranes (BM). The X-linked form of Alport syndrome (XLAS) was described first and is caused by pathogenic variants in the COL4A5 gene on chromosome Xq22.3. The autosomal recessive form of Alport syndrome (ARAS), caused by variants in COL4A3/A4 genes is much rarer. In addition, heterozygous pathogenic variants of the COL4A3/A4 genes on chromosome 2q36 can cause familial intermittent or persistent microscopic hematuria, previously known as benign familial hematuria. This form is extremely frequent with GBM-limited involvement and, according to some authors, represents the autosomal dominant Alport syndrome. This review summarizes the discovery and understanding of Alport syndrome from its description in 1927 to the present day with a longitudinal perspective that integrates historical milestones with emerging insights into pathophysiology and treatment, including promising gene therapy and targeted anti-proteinuric strategies.
中文摘要:Alport综合征(AS)是第二常见的遗传性肾脏疾病。它是一种由编码胶原IV链α3、α4或α5的COL4A3、COL4A4和COL4A5基因中的致病性变异引起的IV型胶原遗传性疾病,而IV型胶原是肾小球基底膜(GBM)的主要结构成分。这导致GBM缺陷,临床上表现为镜下血尿和/或蛋白尿,并可变地伴有感音神经性听力损失和眼科缺陷。在世纪的前半叶,临床医生完善了表型,而病理学家和生物化学家阐明了基底膜的结构异常。X连锁Alport综合征(XLAS)首先被描述,由位于X染色体Xq22.3上的COL4A5基因中的致病性变异引起。常染色体隐性Alport综合征(ARAS)由COL4A3/A4基因中的变异引起,较为罕见。此外,位于2号染色体2q36上的COL4A3/A4基因的杂合致病性变异可导致家族性间歇性或持续性镜下血尿,以前称为良性家族性血尿。这种形式非常普遍,仅涉及GBM,根据一些作者的观点,代表常染色体显性Alport综合征。本综述从纵向视角总结了自1927年描述以来至当今对Alport综合征的发现和理解,将历史里程碑与对病理生理学和治疗的最新见解相结合,包括有前景的基因治疗和靶向抗蛋白尿策略。
Teprotumumab is a novel monoclonal antibody treatment for thyroid eye disease that acts through IGF-1R inhibition. A subset of patients has been reported to experience varying levels of hearing change and other otologic symptoms after therapy. This study aimed to investigate auditory changes following monoclonal antibody IGF-1R inhibitor treatment in mice. Adult CBA/CaJ mice were treated with varying doses of a chimeric IGF-1R monoclonal antibody (cIGF-1R mAb), saline, or IgG2a isotype controls (n = 10 per group) weekly for 20 weeks. Mice underwent auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) testing at regular intervals. Suprathreshold ABR Wave 1 amplitude growth functions were analyzed at the final timepoint, along with histological assessment of auditory hair cells and presynaptic ribbons. Bodyweight, exposure of cIGF-1R mAb, and the inhibitory effect of cIGF-1R mAb in lung tissues were also assessed. At 20 weeks, there was no significant increase in ABR or DPOAE threshold shift of the experimental cIGF-1R mAb groups compared with saline controls. No significant decrease in hair cell and presynaptic ribbon counts or suprathreshold ABR Wave 1 amplitude growth functions were observed amongst cIGF-1R mAb-treated subjects compared with saline controls. Inhibitory activity of cIGF-1R mAb was confirmed by the reduced bodyweight gain compared with controls and sustained IGF-1R pathway inhibition over the study period. IGF-1R inhibition in mice shows no consistent electrophysiologic or histological effect on auditory function. Further animal and clinical studies are warranted to evaluate a potential association between IGF-1R treatment and hearing loss. N/A.
中文摘要:替妥木单抗是一种用于治疗甲状腺眼病的新颖单克隆抗体,其作用机制为抑制IGF-1R。已有报道指出部分患者在治疗后出现不同程度的听力改变及其他耳科症状。本研究旨在探讨小鼠在接受单克隆抗体IGF-1R抑制剂治疗后的听觉变化。成年CBA/CaJ小鼠每周接受不同剂量的嵌合型IGF-1R单克隆抗体(cIGF-1R mAb)、生理盐水或IgG2a同型对照(每组n=10),持续20周。在固定间隔对小鼠进行听觉脑干反应(ABR)和畸变产物耳声发射(DPOAE)测试。在最终时间点分析超阈值ABR第1波振幅增长函数,并对听觉毛细胞和突触前ribbon进行组织学评估。同时评估体重、cIGF-1R mAb暴露情况及其在肺组织中的抑制作用。20周时,与生理盐水对照组相比,实验性cIGF-1R mAb组的ABR或DPOAE阈值偏移无显著增加。与生理盐水对照组相比,cIGF-1R mAb处理组未观察到毛细胞和突触前ribbon计数或超阈值ABR第1波振幅增长函数的显著减少。通过体重增长减少及研究期间持续的IGF-1R通路抑制证实了cIGF-1R mAb的抑制活性。在小鼠中,IGF-1R抑制对听觉功能未表现出一致的电生理或组织学影响。需进一步开展动物和临床研究以评估IGF-1R治疗与听力损失之间的潜在关联。
2头颈外科与肿瘤 (3篇)
临床研究 (3篇)
Metformin has known metabolic effects and associated survival benefits in head and neck cancer. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) also modulate systemic metabolism through regulating blood glucose levels and lipid metabolism. To investigate whether GLP-1RAs are associated with survival outcomes in patients with head and neck cancers. This retrospective cohort study was conducted using clinical data from January 1, 1990, through December 1, 2025, from the TriNetX Global Collaborative Network. Adults with histologically confirmed head and neck squamous cell carcinomas (HNSCC) were included. Data were analyzed in January 2026. The primary outcome was overall survival for all HNSCC and stratified by site. The secondary outcome was overall survival among patients concurrently using GLP-1RAs and metformin. Adjusted hazard ratios (aHRs) with 95% CIs were estimated. There were 4532 patients (mean [SD] age, 63.4 [10.9] years; 1638 female individuals [36.1%] and 2891 male individuals [63.8%]) included in the cohort. Across all subsites, GLP-1RA users had significantly improved overall survival compared with controls at 1-year (aHR, 0.42; 95% CI, 0.36-0.49), 3-year (aHR, 0.48; 95% CI, 0.43-0.54), and 5-year intervals (aHR, 0.51; 95% CI, 0.46-0.57). By anatomic subsite, GLP-1RA use remained consistently associated with a lower hazard of mortality at 5-year intervals (oral cavity: aHR, 0.60; 95% CI, 0.51-0.70; oropharynx: aHR, 0.51; 95% CI, 0.41-0.64; larynx: aHR, 0.49; 95% CI, 0.39-0.61). We also observed significant overall survival among patients who used GLP-1RAs and metformin at 1 year (aHR, 0.29; 95% CI, 0.23-0.36), 3 years (aHR, 0.36; 95% CI, 0.30-0.42) and 5 years (aHR, 0.39; 95% CI, 0.34-0.45). The findings of this cohort study suggest that there may be survival benefits associated with GLP-1RA use among patients with HNSCC across several subsites. Future prospective and interventional studies of GLP-1RA potential metabolic adjuncts in oncologic care may help corroborate the associations from this retrospective study.
中文摘要:二甲双胍在头颈癌中具有已知的代谢效应及相关的生存获益。胰高血糖素样肽-1受体激动剂(GLP-1RAs)通过调节血糖水平和脂质代谢来调节全身代谢。本研究旨在探讨GLP-1RAs是否与头颈癌患者的生存结局相关。这项回顾性队列研究利用TriNetX全球协作网络中1990年1月1日至2025年12月31日的临床数据开展,纳入经组织学确诊的成年头颈部鳞状细胞癌(HNSCC)患者。数据分析于2026年1月进行。主要结局为所有HNSCC患者的总生存率,并按解剖部位分层。次要结局为同时使用GLP-1RAs和二甲双胍患者的总生存率。估算调整后的风险比(aHRs)及95%置信区间(CIs)。队列共纳入4532名患者(平均年龄63.4岁,标准差10.9;女性1638名占36.1%,男性2891名占63.8%)。在所有亚部位中,与对照组相比,GLP-1RA使用者的总生存率在1年(aHR 0.42;95% CI 0.36-0.49)、3年(aHR 0.48;95% CI 0.43-0.54)和5年(aHR 0.51;95% CI 0.46-0.57)时显著改善。按解剖亚部位分析,GLP-1RA的使用在5年时持续与较低的死亡风险相关(口腔:aHR 0.60;95% CI 0.51-0.70;口咽:aHR 0.51;95% CI 0.41-0.64;喉:aHR 0.49;95% CI 0.39-0.61)。我们还观察到,同时使用GLP-1RAs和二甲双胍的患者在1年(aHR 0.29;95% CI 0.23-0.36)、3年(aHR 0.36;95% CI 0.30-0.42)和5年(aHR 0.39;95% CI 0.34-0.45)时的总生存率显著改善。该队列研究的结果表明,在多个亚部位中,HNSCC患者使用GLP-1RA可能存在生存获益。未来关于GLP-1RA作为肿瘤治疗潜在代谢辅助药物的前瞻性研究和干预性研究可能有助于证实本回顾性研究的关联。
To develop and validate an artificial intelligence (AI) system for standardized Ni classification of nasopharyngeal narrow-band imaging (NBI) and to evaluate whether AI assistance improves physician diagnostic consistency and biopsy-related decision making in a reader-study setting. In this multicenter diagnostic study, 5404 high-quality nasopharyngeal NBI images were retrospectively collected. Lesion segmentation and five-class Ni classification networks were trained independently. Performance was evaluated in an internal test set, two independent external cohorts, and a recorded-video validation set. A prospective randomized multi-reader crossover study involving 12 physicians and 200 images from CHSZCAMS assessed the effect of AI assistance on diagnostic performance, inter-observer agreement, and potentially unnecessary biopsy decisions. In the two external cohorts, the model achieved accuracies of 0.889 and 0.873, with AUCs of 0.976 and 0.967, respectively. In recorded-video validation, accuracy was 0.888 and AUC was 0.974. AI assistance improved Fleiss kappa from 0.610 to 0.788 in junior physicians and from 0.744 to 0.870 in senior physicians (both p < 0.05). Potentially unnecessary biopsy decisions decreased from 21.6% to 10.3% in junior physicians and from 13.7% to 8.0% in senior physicians. AI-assisted Ni classification showed consistent diagnostic performance across validation cohorts and improved physician agreement across experience levels. In this reader-study setting, AI assistance reduced potentially unnecessary biopsy decisions, supporting further evaluation as a second-reader tool for nasopharyngeal NBI interpretation.
中文摘要:本研究旨在开发并验证一种用于鼻咽窄带成像(NBI)标准化Ni分类的人工智能(AI)系统,并在读者研究环境中评估AI辅助是否提高医师的诊断一致性和活检相关决策质量。在这项多中心诊断研究中,回顾性收集了5404张高质量的鼻咽NBI图像。独立训练了病灶分割网络和五类Ni分类网络。在内部测试集、两个独立的队列以及录像验证集中评估了模型性能。一项涉及12名医师和200张来自中国中医科学院西苑医院图像的随机多读者交叉试验,评估了AI辅助对诊断性能、观察者间一致性及潜在不必要活检决策的影响。在两个外部队列中,模型的准确率分别为0.889和0.873,AUC分别为0.976和0.967。在录像验证中,准确率为0.888,AUC为0.974。AI辅助使初级医师的Fleiss kappa值从0.610提升至0.788,高级医师从0.744提升至0.870(均p<0.05)。初级医师潜在不必要的活检决策比例从21.6%降至10.3%,高级医师从13.7%降至8.0%。AI辅助Ni分类在验证队列中表现出一致的诊断性能,并提高了不同经验水平医师的一致性。在该读者研究环境中,AI辅助减少了潜在不必要的活检决策,支持其作为鼻咽NBI判读的第二阅片工具进行进一步评估。
Patients with lung and head and neck cancers (L/HNC) face disproportionately high rates of financial toxicity (FT) and persistent smoking after diagnosis, yet the relationship between tobacco use, associated spending, and FT remains poorly understood. This study characterizes this relationship in patients with L/HNC. We conducted a mixed-methods study with semi-structured interviews from 03/2024 to 03/2025 and data analyzed from 07/2024 to 11/2025. Patients with newly diagnosed L/HNC were enrolled through convenience sampling. Transcripts were analyzed using content analysis until thematic saturation. Participants completed the Comprehensive Score for Financial Toxicity (COST) (11-items; 0-44, lower scores represent worse FT), USDA Six-Item Short Form Food Security Module, and smoking-induced deprivation (SID) questionnaire to assess psychosocial, material, and behavioral FT components, respectively. Among 25 participants (13 [52%]) male; 18 (72%) non-Hispanic White; median age 61 years (range, 44-78 years)], 12 (48%) were current smokers at diagnosis. Median COST score was 21 (range 4-43), with 15 (63%) experiencing FT (COST < 26). Eight (33%) patients reported food insecurity. Participants spent a median of $155 (IQR $63-$285) monthly on cigarettes, and 4 (17%) reported SID. Qualitative analysis confirmed an established FT framework and identified tobacco use and spending as a bidirectional contributor to FT. Tobacco use and spending have a bidirectional relationship with FT, contributing to FT across the material, psychosocial, and behavioral domains, while serving as a coping mechanism for financial distress. Our findings underscore the need for integrated smoking cessation and FT interventions alongside targeted FT screening for patients with a smoking history.
中文摘要:肺癌与头颈癌患者面临不成比例的高财务毒性发生率及确诊后持续吸烟现象,但烟草使用、相关支出与财务毒性之间的关系尚不明确。本研究旨在刻画肺癌与头颈癌患者中这一关系。研究采用混合方法,于2024年3月至2025年3月开展半结构化访谈,并于2024年7月至2025年11月分析数据。通过方便抽样纳入新确诊的肺癌与头颈癌患者。转录文本采用内容分析法进行分析直至主题饱和。参与者分别完成综合财务毒性评分量表、美国农业部六项简短版食品安全模块及吸烟诱导剥夺问卷,以评估心理社会、物质和行为维度的财务毒性成分。在25名参与者中(男性13人占52%,非西班牙裔白人18人占72%),中位年龄61岁(范围44至78岁),其中12人(48%)在确诊时为当前吸烟者。中位综合财务毒性评分为21分(范围4至43分),15人(63%)经历财务毒性(评分低于26分)。8名患者(33%)报告食物不安全。参与者每月香烟支出中位数为155美元(四分位距63至285美元),4人(17%)报告吸烟诱导剥夺。定性分析确认了既有的财务毒性框架,并确定烟草使用及支出是财务毒性的双向贡献因素。烟草使用及支出与财务毒性存在双向关系,在物质、心理社会及行为领域促进财务毒性,同时作为应对经济困境的机制。研究结果强调需将戒烟干预与财务毒性干预相结合,并对有吸烟史的患者进行针对性的财务毒性筛查。
3鼻科与鼻窦外科 (2篇)
临床研究 (2篇)
Following the accident at the Fukushima Daiichi Nuclear Power Plant (FDNPP), residents reported symptoms including inflammation of the upper respiratory tract mucosa, eyes, and skin, as well as nosebleeds, headaches, vomiting, abdominal pain, diarrhea, and psychological distress. In response to these concerns, a non-profit organization held free medical consultation sessions staffed by physicians in various locations. The authors investigated the actual health impacts from a medical perspective using an anonymized database compiled from the records of 509 consultation participants. Based on the characteristic symptoms observed, the authors concluded that these health issues stemmed from the chemical toxicity of radioactive cesium hydroxide (R-CsOH) aerosols, which are highly alkaline and corrosive. This study revealed for the first time that these aerosols-which accounted for 90% of the cesium released during the plant's explosions-can cause adverse health effects even at extremely low concentrations. The study presents inductive evidence regarding atmospheric pollution caused by R-CsOH aerosols. The characteristic clinical symptoms identified in this study are noteworthy as a new indicator for assessing human exposure and could serve as a novel warning sign of internal radiation exposure.
中文摘要:福岛第一核电站事故发生后,居民报告出现上呼吸道黏膜、眼睛和皮肤炎症以及鼻出血、头痛、呕吐、腹痛、腹泻和心理困扰等症状。为应对这些担忧,一个非营利组织在各地举办了由医生坐诊的免费医疗咨询活动。作者利用从509名咨询参与者记录中整理的匿名数据库,从医学角度调查了实际健康影响。基于观察到的特征性症状,作者得出结论认为这些健康问题源于放射性氢氧化铯(R-CsOH)气溶胶的化学毒性,该物质呈强碱性且具有腐蚀性。本研究首次揭示这些气溶胶在核电站爆炸释放的铯中占比达90%,即使在极低浓度下也能引起不良健康影响。本研究提供了关于R-CsOH气溶胶造成大气污染的归纳证据。本研究所确定的特征性临床症状值得注意,可作为评估人类暴露的新指标,并可能成为内部辐射暴露的新型警示信号。
Atopic dermatitis is a chronic relapsing inflammatory condition that imposes a considerable burden on children and their families. We aimed to investigate the disease burden and quality-of-life impact across three age groups of children with moderate-to-severe atopic dermatitis. PEDISTAD is an observational global registry of children aged < 12 years with moderate-to-severe atopic dermatitis. Physician-reported disease characteristics, atopic comorbidities, treatment patterns, and patient/caregiver-reported quality-of-life measures are being collected over a period of 10 years. Patients were enrolled in the PEDISTAD Global Registry between September 2018 and April 2024; the data reported here are from a database lock on 31 July 2024. A total of 1612 patients enrolled in PEDISTAD were included in this analysis, of which 238 were aged < 2 years, 645 aged 2 to < 6 years, and 729 aged 6 to < 12 years. The age of onset of atopic dermatitis was early in life. The incidence of asthma, allergic rhinitis, and allergic conjunctivitis increased with age. Mean Eczema Area and Severity Index scores were 14.1, 13.4, and 14.7 for patients aged < 2 years, 2 to < 6 years, and 6 to < 12 years, respectively. With regard to the itch burden and resultant scratching reported by parents and caregivers of the youngest children, the numerical rating score was 5.5 and 5.8 in both 0 to < 2 years and 2 to < 6 years, respectively. For those aged 6 to < 12 years, the itch burden was highest at night, with a Numeric Rating Scale score of 4.9 versus 3.8 during the day. Patient/caregiver-reported measures of disease burden were high for all age groups. The quality of life of the entire family was affected in multiple ways, as measured by the mean Dermatitis Family Impact score, which was higher in children aged < 2 years (12.0) and 2 to < 6 years (11.9), compared with patients aged 6 to < 12 years (10.2). A high/lot of impact was reported on the sleep of the family unit (in children aged < 2 years [45.9%] and 2 to < 6 years [51.9%], compared with patients aged 6 to < 12 years (33.8%). There was a high burden of tiredness and exhaustion among caregivers, particularly in the youngest two age groups but still showing a substantial impact on the families of those aged 6 to < 12 years. Children with moderate-to-severe atopic dermatitis have a high disease burden, with severe itch and poor sleep impacting their own health and quality of life and that of their entire family. ClinicalTrials.gov Identifier: NCT03687359.
中文摘要:特应性皮炎是一种慢性复发性炎症性疾病,给儿童及其家庭带来沉重负担。本研究旨在调查中重度特应性皮炎不同年龄段儿童的疾病负担及生活质量影响。PEDISTAD是一项针对12岁以下中重度特应性皮炎儿童的全球观察性登记研究,收集医师报告的疾病特征、特应性合并症、治疗模式以及患者或照护者报告的生活质量指标,数据收集期为10年。PEDISTAD全球登记研究于2018年9月至2024年4月期间入组患者,本报告数据来源于2024年7月31日的数据库锁定。本次分析纳入PEDISTAD注册的1612名患者,其中年龄小于2岁者238名,2至不足6岁者645名,6至不足12岁者729名。特应性皮炎发病年龄较早。哮喘、过敏性鼻炎和过敏性结膜炎的发病率随年龄增长而增加。年龄小于2岁、2至不足6岁及6至不足12岁患者的平均湿疹面积与严重程度指数分别为14.1、13.4和14.7。针对最年幼儿童家长及照护者报告的瘙痒负担及继发性搔抓,0至不足2岁及2至不足6岁组的数值评分分别为5.5和5.8。对于6至不足12岁的患儿,夜间瘙痒负担最高,数值评分为4.9,白天为3.8。所有年龄段的患者或照护者报告疾病负担均较高。通过平均皮炎家庭影响评分衡量,整个家庭的生活质量在多个方面受到影响,年龄小于2岁(12.0)和2至不足6岁(11.9)儿童家庭的评分高于6至不足12岁儿童家庭(10.2)。家庭单位睡眠受到高程度或大量影响的比例在年龄小于2岁(45.9%)和2至不足6岁(51.9%)儿童中较高,而6至不足12岁儿童为33.8%。照护者疲劳和精疲力竭负担较重,尤其在最年轻的两组中,但对6至不足12岁儿童家庭仍有显著影响。中重度特应性皮炎患儿疾病负担沉重,严重瘙痒和睡眠障碍影响其自身及整个家庭的健康与生活质量。ClinicalTrials.gov标识符:NCT03687359。
4前庭与眩晕 (1篇)
临床研究 (1篇)
Buccinator myomucosal flaps (BMF) are increasingly used for reconstruction of small- to medium-sized intraoral defects because they replace oral mucosa with similar tissue. However, donor-site morbidity and its determinants remain poorly defined. This study aimed to evaluate donor-site morbidity after BMF harvest and identify factors associated with unfavorable outcomes. A retrospective international multicenter cohort study was conducted across 11 centers (10 in Europe and one in India). Adult patients undergoing reconstruction with BMF after oncologic resection and a minimum follow-up of 6 months were included. Donor-site morbidity was assessed during dedicated follow-up visits using a standardized clinical scoring system evaluating mouth opening, oral commissure symmetry, vestibular restoration, cheek lining reconstruction, and cosmetic outcome. A total of 340 patients were included (mean age 58.6 ± 13.9 years; 50% female; mean flap area 14.6 ± 6.2 cm2). The mean donor-site outcome score was 10.7 ± 3.4. At multivariable linear mixed-effects analysis accounting for center, adjuvant radiotherapy or radiochemotherapy and donor-site closure by secondary healing were independently associated with lower scores, whereas the buccal artery myomucosal island flap and the tunnelized facial artery myomucosal island flap were associated with higher scores. Wound dehiscence was the most frequent complication (9.1%). In 223 patients with available data, higher adherence to rehabilitation exercises was associated with improved outcome scores, both with and without adjuvant radiotherapy. BMF provides reliable reconstruction with generally favorable donor-site outcomes. Morbidity is mainly influenced by adjuvant radiotherapy, donor-site management, flap design, and adherence to postoperative rehabilitation exercises.
中文摘要:颊肌黏膜瓣(BMF)因可用相似组织替代口腔黏膜,日益用于小至中等大小口腔缺损的修复。然而,供区并发症及其决定因素尚不明确。本研究旨在评估BMF切取后的供区并发症并识别与不良结局相关的因素。这是一项涵盖11个中心(欧洲10个,印度1个)的国际多中心回顾性队列研究。纳入接受肿瘤切除后BMF重建且随访至少6个月的成年患者。在专门随访访视中,使用标准化临床评分系统评估供区并发症,包括张口度、口角对称性、前庭恢复、颊部衬里重建及美容效果。共纳入340名患者(平均年龄58.6±13.9岁;女性占50%;平均瓣面积14.6±6.2 cm2)。供区结局评分均值为10.7±3.4。多变量线性混合效应分析显示,在校正中心、辅助放疗或放化疗以及供区二期愈合闭合后,辅助放疗或放化疗及供区二期愈合闭合与较低评分独立相关,而颊动脉肌黏膜岛瓣和隧道化面动脉肌黏膜岛瓣与较高评分相关。伤口裂开是最常见的并发症(9.1%)。在223名有数据可查的患者中,较高的康复锻炼依从性与改善的结局评分相关,无论是否接受辅助放疗。BMF提供可靠的修复,供区结局总体良好。并发症主要受辅助放疗、供区管理、瓣设计及术后康复锻炼依从性的影响。
5睡眠呼吸与鼾症 (1篇)
临床研究 (1篇)
To evaluate the effectiveness and safety of adenotonsillectomy in children with cerebral palsy (CP) and obstructive sleep apnea (OSA). A retrospective cohort study was conducted of children with CP and OSA who underwent adenotonsillectomy between 2011 and 2022 at a tertiary pediatric medical center. Inclusion criteria required pre- and postoperative polysomnography within 24 months. Data collected included demographics, comorbidities, perioperative complications, and polysomnography parameters. The primary outcome was the change in obstructive apnea-hypopnea index (OAHI). Secondary outcomes included changes in central apnea index, oxygen nadir, transcutaneous carbon dioxide (TcCO2), and need for noninvasive positive pressure ventilation. Logistic regression identified predictors of postoperative OAHI < 5 events/h. Sixty-five children (median age: 5.0 years) met inclusion criteria. Mean preoperative OAHI was 19.6, which improved to 7.7 postoperatively (p < 0.001). OAHI was reduced by >50% in 63%; 62% achieved OAHI < 5, and 12% achieved OAHI < 1. Oxygen nadir improved from 84% to 88% (p < 0.001), TcCO2 improved from 49.2 mmHg to 45.2 mmHg. No significant change in central apnea index was noted. Postoperatively, 40% required noninvasive positive pressure ventilation, and 55% were electively admitted to the intensive care unit. Complication rate was 12%. Preoperative OAHI was the strongest and most consistently selected predictor of achieving postoperative OAHI < 5 (p = 0.002). Adenotonsillectomy significantly improves OSA severity and oxygenation in children with CP; however, complete resolution is uncommon. Preoperative OAHI severity predicts surgical success. Postoperative polysomnography and multidisciplinary follow-up are essential due to the high rate of residual disease.
中文摘要:评估脑瘫儿童行腺样体扁桃体切除术治疗阻塞性睡眠呼吸暂停的有效性和安全性。本研究为一项回顾性队列研究,纳入2011年至2022年间在某三级儿科医疗中心接受该手术的脑瘫合并阻塞性睡眠呼吸暂停患儿。入组标准要求术前及术后24个月内均有多导睡眠图检查。收集的数据包括人口统计学特征、合并症、围手术期并发症及多导睡眠图参数。主要结局指标为阻塞性呼吸暂停低通气指数的变化。次要结局指标包括中枢性呼吸暂停指数、血氧最低值、经皮二氧化碳分压的变化以及无创正压通气的需求。逻辑回归分析用于识别术后阻塞性呼吸暂停低通气指数低于5次/小时的预测因素。共65名患儿符合入组标准,中位年龄为5.0岁。术前平均阻塞性呼吸暂停低通气指数为19.6,术后改善至7.7(p < 0.001)。63%的患儿该指数降低超过50%,62%达到低于5次/小时,12%达到低于1次/小时。血氧最低值从84%改善至88%(p < 0.001),经皮二氧化碳分压从49.2 mmHg改善至45.2 mmHg。中枢性呼吸暂停指数未见显著变化。术后40%需要无创正压通气,55%被择期收入重症监护室。并发症发生率为12%。术前阻塞性呼吸暂停低通气指数是预测术后达到阻塞性呼吸暂停低通气指数低于5次/小时的最强且最一致的预测因素(p = 0.002)。腺样体扁桃体切除术可显著改善脑瘫儿童的睡眠呼吸暂停严重程度和氧合状况,但完全缓解并不常见。术前阻塞性呼吸暂停低通气指数的严重程度可预测手术成功率。由于残留疾病发生率高,术后多导睡眠图监测和多学科随访至关重要。
6其他 (3篇)
临床研究 (2篇)
Zopapogene Imadenovec-drba Treatment for Adults With Recurrent Respiratory Papillomatosis: A Review.
After the US Food and Drug Administration approval of zopapogene imadenovec-drba and its recommendation as the first-line treatment for recurrent respiratory papillomatosis (RRP) in the RRP Foundation Position Statement, standard-of-care treatment for adults with RRP is changing. Practical questions arise with real-world implementation for any new treatment previously studied only in clinical trials. This Narrative Review aims to provide additional information beyond what is published in clinical trial reports to help otolaryngologists and medical oncologists consider how to implement zopapogene imadenovec-drba in their RRP practices. In the pivotal phase 1/2 nonrandomized clinical trial, 51% of patients (18 of 35) achieved a complete response, defined as no clinically indicated surgical procedure received in the 12 months after treatment. This review provides further key information underlying the rationale behind the zopapogene imadenovec-drba pivotal trial design and considerations for clinical implementation and in specific populations. Zopapogene imadenovec-drba represents a novel immunotherapeutic approach designed to induce targeted durable disease control in adult RRP. This review provides practical guidance on patient selection, treatment administration, and perioperative management to support the clinical integration of nonsurgical management into routine otolaryngology and medical oncology practice.
中文摘要:在美国食品药品监督管理局批准zopapogene imadenovec-drba并推荐其为复发性呼吸道乳头状瘤病(RRP)的一线治疗后,成人RRP的标准治疗方案正在发生改变。对于此前仅在临床试验中研究过的新疗法,其在真实世界实施过程中会出现实际性问题。本叙述性综述旨在提供临床试验报告之外更多信息,帮助耳鼻喉科医生和肿瘤内科医生考虑如何在RRP诊疗实践中应用zopapogene imadenovec-drba。在关键的1/2期非随机临床试验中,51%的患者(35例中的18例)达到完全缓解,定义为治疗后12个月内未接受任何临床指示的手术治疗。本综述提供了进一步的关键信息,包括zopapogene imadenovec-drba关键试验设计的理论基础以及特定人群临床实施的考量。Zopapogene imadenovec-drba代表了一种新型免疫治疗方法,旨在诱导成人RRP患者获得靶向且持久的疾病控制。本综述为患者选择、治疗给药及围手术期管理提供实用指导,以支持将非手术治疗整合到常规耳鼻喉科和肿瘤内科实践中。
Characterize patient portal messaging patterns in pediatric otolaryngology, assess sociodemographic predictors of portal use, and evaluate the impact of messaging on clinical care delivery. This retrospective cohort study included all patients ≤ 18 years of age seen in an urban academic pediatric otolaryngology practice January-December 2023. Demographic and clinical data were extracted from the EMR. Portal users were defined as patients or proxies who initiated ≥ 1 message. Message content and associated clinical outcomes were categorized. Chi-square testing and multivariable logistic regression were used to identify predictors of portal use. Among 1864 patients, 82 (4%) were portal users. Users were more likely to be younger (aOR 0.91 per year; 95% CI, 0.87-0.97; p = 0.003), English-speaking (98.8% vs. 75.3%; p < 0.001), and commercially insured (80.5% vs. 44.3%; p < 0.001). Non-English speakers (aOR 0.11; 95% CI, 0.01-0.80; p = 0.030) and patients with Medicaid (aOR 0.29; 95% CI, 0.10-0.83; p = 0.02) or Medicaid replacement insurance (aOR 0.31; 95% CI, 0.16-0.63; p < 0.001) were significantly less likely to use the portal. Race and ethnicity were not independent predictors after adjustment. Messaging resulted in direct clinician response in 52% of cases and led to expedited care in 17%. Patient portal messaging in pediatric otolaryngology demonstrates inequitable utilization, with markedly lower engagement among non-English speaking and publicly insured families. Given its potential to facilitate timely care, disparities in portal use may represent an important source of inequity in pediatric surgical care. N/A.
中文摘要:本研究旨在描述儿科耳鼻喉科患者门户消息模式,评估门户使用的社会人口学预测因素,并评估消息对临床护理交付的影响。这项回顾性队列研究纳入了2023年1月至12月在城市学术儿科耳鼻喉科诊所就诊的所有年龄≤18岁的患者。人口统计学和临床数据从电子病历中提取。门户用户定义为发起≥1条消息的患者或代理人。对消息内容和相关临床结果进行分类。使用卡方检验和多变量逻辑回归来识别门户使用的预测因素。在1864名患者中,82人(4%)是门户用户。用户更可能是年轻人(每岁aOR 0.91;95% CI,0.87-0.97;p=0.003)、讲英语者(98.8% vs. 75.3%;p<0.001)和商业保险患者(80.5% vs. 44.3%;p<0.001)。非英语使用者(aOR 0.11;95% CI,0.01-0.80;p=0.030)、 Medicaid患者(aOR 0.29;95% CI,0.10-0.83;p=0.02)或 Medicaid替代保险患者(aOR 0.31;95% CI,0.16-0.63;p<0.001)使用门户的可能性显著较低。调整后的种族和民族不是独立预测因子。消息在52%的情况下导致直接临床医生回应,并在17%的情况下导致加速护理。儿科耳鼻喉科患者门户消息显示出不平等的利用情况,非英语使用者和公共保险家庭的参与度明显较低。鉴于其促进及时护理的潜力,门户使用的差异可能代表儿科外科护理中不公平的重要来源。
基础研究 (1篇)
The exponential growth in medical literature has strained traditional evidence synthesis approaches, prompting interest in artificial intelligence (AI) as a potential solution. Thus, we sought to assess the concordance and time savings between humans and AI in the systematic review process for a specialized otolaryngology topic. A mock systematic review on immunotherapy for HPV+ oropharyngeal squamous cell carcinoma was conducted. Title/abstract and full-text were independently performed by human reviewers using Covidence and by Claude by Anthropic, model Sonnet 3.7. Concordance at each phase was assessed with sensitivity and specificity, and total time expenditure was documented for both approaches. Claude Sonnet 4.5 was subsequently applied to full-text screening of a published systematic review as proof-of-concept validation. Of the 1337 abstracts screened, human reviewers identified 43 for full-text review and ultimately included 17 manuscripts. Claude demonstrated an overall sensitivity of 17.6% (3/17) and specificity of 96.3% (1271/1320) when performing independent screening of all abstracts. When provided human-curated abstracts for full-text screening in an "AI-assisted" methodology, it achieved 100% (17/17) sensitivity and 57.7% (15/26) specificity. Validation against a published review achieved 100% sensitivity and 97.8% specificity. AI-driven screening required 325 active human minutes versus 1340 m for traditional human review, representing a theoretical active human time savings of over 75%. While AI cannot yet replace human judgment in systematic reviews, hybrid methodologies combining AI speed with human clinical expertise may represent the most promising approach for maintaining both efficiency and quality in evidence synthesis for rapidly evolving medical fields. N/A.
中文摘要:医学文献的指数级增长给传统证据综合方法带来压力,促使人们关注人工智能作为潜在解决方案。本研究旨在评估在特定耳鼻喉科主题的系统评价过程中,人类与人工智能之间的符合度及时间节省情况。我们针对HPV阳性口咽鳞状细胞癌的免疫治疗开展了一项模拟系统评价。使用Covidence平台由人类评审员独立进行标题摘要筛选和全文筛选,同时由Anthropic公司的Claude模型Sonnet 3.7执行相同任务。通过敏感性和特异性评估各阶段的符合度,并记录两种方法的总时间消耗。随后将Claude Sonnet 4.5应用于已发表系统评价的全文筛选作为概念验证。在筛查的1337篇摘要中,人类评审员识别出43篇进行全文审查并最终纳入17篇文献。Claude在对所有摘要进行独立筛选时,总体敏感性为17.6%(3/17),特异性为96.3%(1271/1320)。当提供由人类筛选的摘要用于全文筛选时,采用AI辅助方法实现了100%(17/17)的敏感性和57.7%(15/26)的特异性。与已发表评价的验证结果显示敏感性为100%,特异性为97.8%。AI驱动的筛选仅需325分钟的人类主动时间,而传统人类审查需1340分钟,代表理论上超过75%的人类主动时间节省。虽然AI目前尚不能取代系统评价中的人类判断,但结合AI速度与人类临床专业知识的混合方法可能是维持快速演变医学领域证据综合效率与质量的最具前景的方法。